Review Article
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
Table 3
OR for goal attainment and response rates in patients not at goal with A5 monotherapy.
| Goal or response target (mm Hg) | A10 versus A5 OR (95% CI) | T40/A5 versus A5 OR (95% CI) | T80/A5 versus A5 OR (95% CI) |
| BP < 140/90 | 2.13 (1.49, 3.05) | 3.07 (2.34, 4.04) | 3.43 (2.54, 4.64) | DBP < 90 | 2.24 (1.58, 3.19) | 2.62 (2.00, 3.44) | 3.00 (2.22, 4.07) | DBP < 90 or reduction 10 | 2.12 (1.53, 2.96) | 2.71 (2.10, 3.51) | 2.73 (2.05, 3.65) | SBP < 140 | 1.94 (1.35, 2.81) | 2.99 (2.24, 4.00) | 3.25 (2.37, 4.48) | SBP < 140 or reduction 20 | 1.90 (1.36, 2.68) | 2.69 (2.06, 3.52) | 2.86 (2.11, 3.90) |
|
|
A5: amlodipine 5 mg; A10: amlodipine 10 mg; BP: blood pressure; CI: confidence interval; DBP: diastolic blood pressure; OR: odds ratio; SBP: systolic blood pressure; T40: telmisartan 40 mg; T80: telmisartan 80 mg.
|